Catherine Bresson
Director, Operational Team, WIN Consortium
Executive committee
Wafik El-Deiry
Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)
Razelle Kurzrock
Chief Medical Officer, WIN Consortium; Prof. of Medicine, Associate Director Clinical Research, MCW Cancer Center and Linda T. & John A. Mellowes Chair of Precision Oncology (USA)
Yves A. Lussier
Chairman, Scientific Advisory Board, WIN Consortium; Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)
Jacques Raynaud
Senior adviser to WIN Strategy, Science and Fundraising, WIN Consortium
Richard L. Schilsky
Chair Emeritus, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)
Marina Sekacheva
Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)
Operational team
Catherine Bresson
Director, Operational Team, WIN Consortium
Layla El-Gharras
Assistant, Operational Team, WIN Consortium
Shai Magidi
IT Data Management, WIN Consortium
Eitan Rubin
Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)
Fanny Wunder
Project Manager, WIN Consortium
Scientific Advisory Board
Gerald Batist
Director, Segal Cancer Centre, Sir Mortimer B. Davis-Jewish General Hospital (Canada)
Ioana Berindan-Neagoe
Director of Research Center of Functional Genomics, Biomedicine and Translational Medicine, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)
Anton Buzdin
Head of Laboratory for Clinical Genomic Bioinformatics; Head of Genomic Center; Sechenov First Moscow Medical University (Russia)
Benedito A. Carneiro
Co-Leader Cancer Therapeutics Program, Legorreta Cancer Center at Brown University (USA)
Stanley R. Hamilton
Vice Chair, Scientific Advisory Board, WIN Consortium; Chair and Professor, Department of Pathology, City of Hope Comprehensive Cancer Center (USA)
Roy S. Herbst
Ensign Professor of Medicine; Chief of Medical Oncology; Deputy Director of Yale Cancer Center and Smilow Cancer Hospital (USA)
Paul Hofman
Professor of Pathology, Nice Sophia Antipolis University (France)
Yves A. Lussier
Chairman, Scientific Advisory Board, WIN Consortium; Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)
John Quackenbush
Henry Pickering Walcott Professor of Computational Biology and Bioinformatics and Chair, Dept of Biostatistics, Harvard T.H Chan School of Public Health (USA)
Gideon Rechavi
Head, Sheba Cancer Research Center, Chaim Sheba Medical Center (Israel)
Eytan Ruppin
Branch Chief, Cancer Data Science Laboratory (CDSL), National Institute of Health (NIH) (USA)
Lillian Siu
Director of Phase I Trials Program, BMO Chair in Precision Cancer Genomics, Princess Margaret Cancer Centre and Professor of Medicine, University of Toronto (Canada)
Directorate
Zhen Chen
Vice President, Fudan University Shanghai Cancer Center (China)
Cristiano de Pádua Souza
Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Wafik El-Deiry
Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)
Ni Ming
Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)
Alejandro Piris
Chief Scientific Officer, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Angel Porgador
Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)
C.S. Pramesh
Director, Tata Memorial Hospital; Professor, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)
Eitan Rubin
Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)
Pierre Saintigny
Medical Oncologist, Professor of Medicine at University Claude Bernard Lyon, Coordinator of the Translational Medicine Unit at Centre Léon Bérard (France)
Marina Sekacheva
Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)
Benjamin M. Solomon
Medical Oncologist, Avera Cancer Institute (USA)
Casey Williams
Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)
General Assembly
Hikmat Abdel-Razeq
Professor and Chairman, Department of Medicine, Chief Medical Officer and Deputy Director General King Hussein Cancer Center (Jordan)
Amal Al Omari
Chief Scientific Officer, King Hussein Cancer Center (Jordan)
Humaid Al-Shamsi
Director of Oncology Services at Burjeel Holdings (UAE & GCC), (United Arab Emirates)
Satoru Aoyama
Assistant Professor, Institute of Science Tokyo Hospital (Japan)
Adel Aref
Oncology Team Lead, Senior Researcher, Procan® - Children’s Medical Research Institute (CMRI) (Australia)
Gerald Batist
Director, Segal Cancer Centre, Sir Mortimer B. Davis-Jewish General Hospital (Canada)
Guy Berchem
Head of Haemato-Oncology department, Centre Hospitalier de Luxembourg; Associate Medical Director, Luxembourg Institute of Health (Luxembourg)
Raanan Berger
Director, Institute of Oncology, Sheba Medical Center (Israel)
Ioana Berindan-Neagoe
Director of Research Center of Functional Genomics, Biomedicine and Translational Medicine, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)
Jean-Yves Blay
General Director, Centre Léon Bérard (France)
Rares Buiga
Head of Pathology Department, The Oncology Institute Ion Chiricuta (IOCN) (Romania)
Anca Dana Buzoianu
Rector, The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)
David Cantú de León
Director of Research, Instituto Nacional de Cancerologia (INCan)(Mexico)
Benedito A. Carneiro
Co-Leader Cancer Therapeutics Program, Legorreta Cancer Center at Brown University (USA)
Andrés Cervantes
Head of Department, INCLIVA (Spain)
Zhen Chen
Vice President, Fudan University Shanghai Cancer Center (China)
William L. Dahut
Chief Scientific Officer, American Cancer Society (USA)
Cristiano de Pádua Souza
Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Said Dermime
Senior Scientist/ Director of Translational Cancer Research Facility, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)
François Dupré
Director General, Fondation ARC (France)
Wafik El-Deiry
Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)
Carol Farhangfar
Assistant Vice President, Translational Research, Wake Forest Baptist Comprehensive Cancer Center/Atrium Health (USA)
Amanda Ferraro
Patient Advocate, Author, Freelance Writer, Cancer is an A* LLC (USA)
Naftali Z. Frankel
Director of Precision Medicine Innovation, Chaim Medical Resource, Org, (USA)
Himabindu Gaddipati
Founder and Managing Director, Vyas Cancer Research Pvt (VCR Park) (India)
Shridar Ganesan
Professor of Medicine & Pharmacology, Rutgers Cancer Institute of New Jersey (CINJ), (USA)
Manon Gantenbein
Head of Clinical and Epidemiological Investigation Center (CIEC) & Clinical Project Management Office (CPMO), Luxembourg Institute of Health (Luxembourg)
Eugenia Girda
Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences and Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey (CINJ), (USA)
Leah Graham
Program Director, Maine Cancer Genomics Initiative, The Jackson Laboratory (USA)
Sadakatsu Ikeda
Professor, Deputy Director, Institute of Science Tokyo Hospital (Japan)
Simon Istolainen
Chief Strategy and Scientific Network, Cure51 (France)
John Jiang
Senior Director of Global Medical Affairs for Oncology, Illumina (USA)
Anthony Joshua
Head of Department, Department of Medical Oncology, The Kinghorn Cancer Centre, St Vincent's Hospital (Australia)
Mandar Kulkarni
CEO and Director, Vyas Cancer Research Pvt (VCR Park) (India)
Ulrik Lassen
Head of Department, Professor, Rigshospitalet (Denmark)
Juan Martín Liberal
Consultant Medical Oncologist Melanoma, Sarcoma and GU Tumors Unit Early Drug Development Unit, Catalan Institute of Oncology (ICO)(Spain)
Sewanti Limaye
Director of Medical & Precision Oncology, Director Oncology, Director Clinical & Translational Oncology Research, Sir H.N. Reliance Foundation Hospital & Research Centre (India)
Jia Liu
Staff Specialist Medical Oncology and Translational Lead of Phase 1 Unit, The Kinghorn Cancer Center, St Vincent's Hospital (Australia)
Chetan Madre
Oncology Research- Manager, Sir H.N. Reliance Foundation Hospital & Research Centre (India)
Ruben A. Mesa
President, Atrium Health Levine Cancer Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center (USA)
Ni Ming
Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)
Khaled Musallam
Group Chief Research Officer for Burjeel Holdings (VPS Healthcare) at Burjeel Medical City in Abu Dhabi, (United Arab Emirates)
Finn Cilius Nielsen
Professor, Centre for Genomic Medicine, Rigshospitalet (Denmark)
Amir Onn
Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)
Jim Palma
Executive Director of TargetCancer Foundation (USA)
Alejandro Piris
Chief Scientific Officer, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Angel Porgador
Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)
C.S. Pramesh
Director, Tata Memorial Hospital; Professor, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)
Roger Reddel
Executive Director, Children's Medical Research Institute (CMRI) Head, Cancer Research Unit, ProCan® - Children’s Medical Research Institute (CMRI) (Australia)
Rui Manuel Reis
Scientific Director, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Abdul Rouf
Senior Research Scientist – Director of Clinical Trial Unit, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)
Eitan Rubin
Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)
Jens Rueter
Chief Medical Officer, Jackson Laboratory & Medical Director – Maine Cancer Genomics Initiative, The Jackson Laboratory (USA)
Pierre Saintigny
Medical Oncologist, Professor of Medicine at University Claude Bernard Lyon, Coordinator of the Translational Medicine Unit at Centre Léon Bérard (France)
Ramón Salazar
General Director, Catalan Institute of Oncology (ICO)(Spain)
Mohamed E. Salem
Clinical Associate Professor, Hematology and Oncology, Wake Forest Baptist Comprehensive Cancer Center/Atrium Health (USA)
Pessie Schlafrig
Co-founder and Director, Chaim Medical Resource, Org (USA)
Marina Sekacheva
Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)
Manju Sengar
Professor, Medical Oncology - Tata Memorial Center (India)
Shambhavi Singh
Precision Oncology Research Fellow, Division of Precision Oncology and Medical Oncology, Sir H N Reliance Foundation Hospital and Research Centre (India)
Benjamin M. Solomon
Medical Oncologist, Avera Cancer Institute (USA)
Andrey A. Svistunov
First Vice Rector, I.M Sechenov First Moscow State Medical University (Russia)
Josep Tabernero
Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Mohammed Ussama Al Homsi
Senior Consultant Oncology, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)
Catalin Vlad
General Manager of Oncology, The Oncology Institute Ion Chiricuta (IOCN) (Romania)
Casey Williams
Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)
Nicolas Wolikow
Chief Executive Officer, Cure51 (France)